In 2023, Alimentary Tract and Metabolism Medicine Sales in Australia were valued at 1.28 billion dollars. The sales showed a year-on-year increase of 2.2%, following a 2.19% rise in 2022 and a significant 19.45% growth in 2021. From 2024 onwards, the market is forecasted to grow steadily, with a 5-year CAGR of 1.57%, which is an indication of moderate growth over the period. The forecast points towards 8.12% overall growth by 2028.
Key trends over the past decade include fluctuations with notable declines and slow recovery phases, culminating in a positive growth trajectory around the 2020s. The average annual growth rate over the last five years stood at 4%, suggesting gradual recovery and stabilization in sales.
Future trends to watch for include advancements in personalized medicine, increasing prevalence of gastrointestinal and metabolic disorders, and the integration of digital health solutions which could significantly impact market growth and consumer behavior.
